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Abstract. In a health system increasingly driven by cost constraints, there is a focus 
on improved electronic transfer of information to support healthcare delivery. One 
area of healthcare that has moved more quickly than others to achieve this is 
prescribing in the primary care environment. Whilst the move to electronic transfer 
of prescriptions has reduced transcription errors, the regulatory environment 
persists with handwritten signatures. This constraint, whilst addressed slowly with 
technology solutions, needs support from legislative change. The ultimate step is to 
have a secure mobile model, which would support the move to a fully-electronic, 
paperless transaction model.  
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Introduction 
The National Health and Hospital Reform Commission (NHHRC) recognises that e-
health plays a vital role in realising Australia’s health reform recommendations [1], and 
is the key to improving Australian healthcare system whilst supporting a maintainable 
system [2]. Electronic Transfer of Prescriptions (eTP) is an important contributor in an 
e-health-enabled healthcare system that ensures medicines information is accurately and 
securely shared, providing a range of healthcare benefits for both prescribers and 
consumers [3, 4]. In an environment where 209.8 million prescriptions were filled in the 
2013-2014 financial year, an increase of 6.3% on 2012-2013, streamlining the 
prescription process is vital [5]. This is achieved through sharing of precise patient 
medication information between prescriber and dispenser [3]. The eTP process allows 
for electronic generation of a prescription by a prescriber and electronic signature 
authentication, which is then transmitted securely to a pharmacy. 
As the demand for mobile applications to support healthcare provision grows, there 
is a need to explore opportunities and seek solutions to the issues of secure transmission 
and use of data for health in a mobile environment. This paper uses eTP as an example 
of the pathway of technological development from the paper based manual prescription 
process to a fully mobile, paperless paradigm. It reviews the existing methods of 
transfer of prescription information including current practice, software capabilities, and 
regulation and legislative constraints at the Commonwealth, State, and Territory levels. 
Instead of simply providing a comparative review of various implementations, it 
presents a snapshot of the current situation in order to provide a context and further it 
proposes a new mobile fully-electronic solution. 
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1. Methods for Transfer of Prescriptions 
As both hardware and software technology have evolved, there has been a progression 
in information transfer from a manual prescribing process to a hybrid manual/electronic 
solution. Figure 1 demonstrates the conventional manual prescribing model with the 
prescriber writing on a pre-printed prescription pad. Once signed, the prescription is 
given to the patient, who then presents it to the pharmacy where the prescription details 
are transcribed into an electronic pharmacy dispensing system for dispensing. This 
information is also used for Pharmaceutical Benefits Scheme (PBS) claiming and repeat 
dispensing. This process may include verification of the prescription details with the 
prescriber, and it is vulnerable to loss of the prescription by the patient, as well as 
transcription errors in the pharmacy data-entry process. 
 
 
 
Figure 1. Manual prescribing process. 
 
 
The introduction of the Practice Incentive Program (PIP) by the Australian 
Government for desktop computing in general practice in the late 1990’s, saw the 
transition to printed prescriptions and subsequently electronic process inclusion as part 
of the prescribing workflow [6]. 
 
 
 
Figure 2. Current electronic prescription transfer process. 
 
 
Figure 2 describes the prescribing model currently used by 95.7% of GPs in 
Australia [7]. This model implements eTP technical specification. eTP version 1.1 uses 
the Prescription Exchange Service (PES), Electronic Prescribing System (EPS) and 
Electronic Dispensing System (EDS) as key elements: 
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 The Prescription Exchange Service (PES) is an intermediary service, which 
enables secure transmission of electronic prescription information between 
prescribers and dispensers [8]. 
 The Electronic Prescribing System (EPS) is a component of the prescriber’s 
clinical software package for generating an electronic prescription, digitally 
signing it and uploading it to the PES [8]. 
 The Electronic Dispensing System (EDS) is a pharmacy software component, 
which downloads the electronic prescription from the PES and submits 
dispense-records to the PES upon dispensing [8]. 
In this model, GPs use clinical software that has an EPS component for generating 
prescriptions and upload to one of two script exchanges (PES). Each electronically 
generated prescription is identified by a unique Document Access Key (DAK), which is 
provided to the patient encoded as a barcode on the printed and signed Prescription 
Notification slip. The slip contains information identical to the prescription. When the 
slip is presented to the pharmacy, the prescription detail is downloaded by the 
pharmacy’s eTP enabled EDS from the PES, using the DAK, as shown in Figure 2. This 
eliminates the need for verification of the prescription details, and transcription errors. 
The downloaded prescription is used to dispense the medication and for secondary uses 
such as PBS claiming. The EDS then provides a record of the dispensed medication to 
the PES. Whilst existing, the automatic dispense notification service to the originating 
prescriber is currently disabled at the request of the Royal Australian College of General 
Practitioners, due to potential implications for clinician duty of care [12]. 
A mobile application from one PES supplier was released in 2014 to enhance this 
process model (Figure 2) by allowing patients to scan the DAK barcode from the 
prescription to their mobile phone, and submit it to their choice of pharmacy, securely 
for a scheduled pickup. This model still uses the printed Prescription Notification with 
prescription details as a transfer medium for passing the DAK between the prescriber 
and dispenser. The prescriber’s signature on the printed prescription is mandated by 
relevant Acts/Regulations (e.g. Poison Regulation 1965 Regulation 51.(1B) in Western 
Australia). This requirement will be replaced once the use of digitally signed electronic 
prescriptions has legislative approval. 
2. Adoption Potential and Related Issues  
Figure 3 depicts the levels of eTP adoption, the extent to which eTP is implemented, 
and its influence on the information workflow and the form in which the information is 
communicated. The level of adoption of eTP varies across the different sectors of the 
healthcare industry, despite being a key government initiative to improve the delivery 
and quality of healthcare.  
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Figure 3. Level of eTP adoption [9]. 
 
 
In Level 1 the printed prescription is both the legal prescription for dispensing and 
the transfer medium for delivering the DAK identifier to the dispenser. Having the 
prescription details printed with the DAK benefits the patient, as the printed prescription 
details may be used for dispensing if the pharmacy’s EDS is not eTP enabled or access 
to PES is not available. However, this requires the printed prescription to have the 
prescriber’s handwritten signature on it as mandated by the s. 51(1B) of the Poisons 
Regulations 1965 in WA and similar legislation in other States. However, using a data 
storage device as the transfer media for the electronic prescription, instead of the printed 
paper version, means the written signature of the prescriber is no longer required as it is 
exempted by the s. 51 (1A) and s. 51(1C) of the Poisons Regulations 1965, and s. 9(1) 
and s. 9(3) of the Electronic Transaction Acts 1999. 
Level 2 adoption uses the printed prescription notification as a transfer medium for 
delivering the identifying DAK to the dispenser. The printed prescription notification 
also contains the same prescription details as the electronic prescription thus facilitating 
dispensing if access to PES is not available. However, the same principles and 
restrictions apply as in Level 1 with regard to the prescriber’s handwritten signature. In 
the current electronic prescription transfer process, the pharmacy’s eTP enabled EDS 
downloads the prescription details from the PES using the DAK, upon receiving the 
printed prescription or the prescription notification submitted by the patient/agent.  
Level 3 allows for the same conditions as Level 2 but replaces the paper 
notification with a fully-electronic notification.  
3. Designing Solutions to Meet Compliance  
Whilst the Australian Government has removed Commonwealth legislative barriers to 
electronic prescribing, by implementing changes to the National Health (Pharmaceutical 
Benefits) Amendment Regulations 2006, the State and Territory legislative barriers 
remain. Alignment with Commonwealth amendments is occurring slowly, and this will 
provide rules for electronic prescribing and dispensing in the respective jurisdictions. 
Table 1 lists the Commonwealth, as well as State and Territory Acts and Regulations 
that have been repealed and/or amended to accommodate implementation of eTP. 
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Table 1. Commonwealth, State and Territory Acts enabling the implementation of eTP. 
Jurisdiction Acts/Regulation 
Commonwealth Electronic Transactions Act 1999 
Commonwealth National Health Act 1953; National Health (Pharmaceutical Benefits) Regulations 1960 
NSW Poisons and Therapeutic Goods Regulation 2008 
VIC Drugs, Poisons and Controlled Substances Regulations 2006 
QLD Health (Drugs and Poisons) Regulation 1996 
WA Poisons Act 1964; Poisons Regulations 1965 
SA Controlled substances Act 1984; Controlled substances (Poisons) Regulations 2011 
TAS Poisons Act 1971; Poisons Regulations 2008 
ACT Medicines, Poisons and Therapeutic Goods Act 2008; Medicines, Poisons and 
Therapeutic Goods Regulations 2008 
NT Medicines, Poisons and Therapeutic Goods Act 2012 
 
 
Other standards, specifications, and principles that support and govern the 
implementation of eTP in Australia include: Electronic Transactions Act 1999 
(Commonwealth) and Electronic Transactions Act 2011 (WA), Australian Privacy 
Principles 2014, ATS 4888.1–7 (2013) Electronic transfer of prescriptions using Health 
Level 7 (HL7) Clinical Document Architecture (CDA), and AS 4700.3-2014 - 
Electronic messages for exchange of information on medicines prescription using HL7 
V2.5. Whilst not exhaustive, this highlight the complexity of designing solutions. In 
other words, these Acts, regulations, and standards influence the legislative 
requirements and specifications that must be met in design and development of eTP. 
4. A New, Fully Mobile Solution 
Whilst the Electronic Transactions Act 1999 primarily supports the creation, transfer 
and storage of the electronic prescription, amendments 51(1A) and 51(1C) of the 
Poisons Regulations 1965 effectively allows an electronic prescription to be a legal 
document without the prescriber’s written signature. Combined with other changes in 
governance the Commonwealth and States have made to enable e-health, these two 
amendments are sufficient to support an ETP Level 3 model.  
 
 
 
Figure 4. Proposed fully-electronic mobile prescription transfer process. 
 
 
A fully-electronic mobile prescription transfer model is proposed (Figure 4). The 
EPS generates an electronic prescription, encrypts it using the DAK as per the data 
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security conformance guidelines in ATS4888.2, signs the DAK with the prescriber’s 
Medicare digital certificate, and then transfers it to the patient’s mobile device. The use 
of digital certificates not only provides a way to authenticate the prescriber but also 
assures the confidentiality and integrity of the information transferred. The encrypted 
electronic prescription is stored on the mobile device in the same way it is stored within 
the PES in the current prescribing model. When presented at the pharmacy, the 
encrypted prescription and DAK are transferred to the pharmacy system, the 
prescriber’s digital certificate is verified, and then the prescription is decrypted using 
the DAK. This model bypasses the PES entirely by using the mobile device as the 
transfer medium for the electronic prescription. Once dispensed, the pharmacy’s EDS 
uploads the dispensing information into the NPDR. In this model, the prescription is 
issued and transferred in fully-electronic form, thus removing the requirement for the 
prescriber’s written signature in accordance with section 51(1A) of the Poisons 
Regulations 1965.  
This proposed eTP transfer model supports eTP adoption stages Levels 1 to 3 as 
long as there is a mechanism to transfer the electronic prescription from the prescriber’s 
EPS to the mobile storage device and from the mobile storage device to the dispenser’s 
EDS securely. This model is envisaged to use Near Field Communication (NFC) 
technology as the preferred transfer mechanism. NFC is designed for use in close 
proximity (i.e. up to a few centimetres) for secure data transfer and supports strong 
security features that facilitate highly secure transfer and storage of data. The NFC 
technology’s reliability and practicality is evident by its use in the banking industry (e.g. 
Commonwealth Bank for its product, Tap & Pay). Nevertheless, this preference of 
employing NFC for data transfer is not based solely on the technical viability but also 
on the consumer acceptance and confidence in the technology. NFC’s simplicity from a 
user perspective, enables easy information sharing NFC is now available on all recent 
model mobile phones. In the current hybrid transfer model, the PES makes uploaded 
prescriptions available to dispensers as well as preventing access to those that have been 
cancelled, are expired or fully dispensed. For that purpose, PES updates the dispensing 
state of each prescription after each dispense. In the proposed model, the smart phone 
utilised as the mobile storage device makes the prescription available to the dispensers 
and the dispensing state of the prescription is updated by the dispenser’s EDS directly to 
the mobile storage device. Due to the connectionless nature of the proposed model, 
cancelling the prescription by the prescriber requires additional services such as SMS to 
update remotely the dispensing state of the prescriptions stored on the mobile device 
5. Conclusion 
The Commonwealth, States, and Territories have repealed and/or amended Acts and 
Regulations, and developed and adopted many standards and specifications in order to 
pave the way for implementing eTP. The legislative approval for the legal use of 
digitally signed electronic prescription is one of the last steps supporting the efficient 
use of electronic information communication in electronic prescribing. The proposed 
model can be implemented within the existing legislative framework, reduces 
complexity, and removes the need for ongoing major supporting infrastructure with its 
associated cost. In addition, users will be empowered and reassured that their sensitive 
medication data is not available to third parties. The model is very efficient and does not 
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require internet connectivity for basic functionality. Therefore, it provides an effective 
solution in all areas including remote locations with poor or no connectivity. 
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